Journals / Türk Onkoloji Dergisi / 2006 / Cilt: 21 - Sayı: 1

Curative radiotherapy in early stage glottic laryngeal carcinoma

Erken evre glottik larenks kanserlerinde küratif radyoterapi

Pages
28–36
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Five year disease specific survival rates were 94% in T1 and 79% in T2 patients, T stage and radiotherapy interruption more than 5 days were noted as prognostic factors affecting disease specific survival.CONCLUSION Curative radiotherapy is an effective treatment modality in early stage glottic laryngeal cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES To evaluate the prognostic factors and the treatment results in early stage glottic laryngeal carcinoma patients treated with radiation therapy.METHODS The records of 83 patients (80 males; 3 females; mean age 62 years; range 40 to 85 years) treated with radical radiotherapy at Ege University Medical School Department of Radiation Oncology during January 1995-December 2004 were studied retrospectively.RESULTS Twenty-nine patients had (34.9%) T1a, 29 patients had (34.9%) T1b and 25 patients had (30.1%) T2 stage disease.
📊
Key Findings & Data:During a median follow-up of 56 months, 13 patients had failures.
💡
Conclusion & Impact:Five year disease specific survival rates were 94% in T1 and 79% in T2 patients, T stage and radiotherapy interruption more than 5 days were noted as prognostic factors affecting disease specific survival.CONCLUSION Curative radiotherapy is an effective treatment modality in early stage glottic laryngeal cancer.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES To evaluate the prognostic factors and the treatment results in early stage glottic laryngeal carcinoma patients treated with radiation therapy.METHODS The records of 83 patients (80 males; 3 females; mean age 62 years; range 40 to 85 years) treated with radical radiotherapy at Ege University Medical School Department of Radiation Oncology during January 1995-December 2004 were studied retrospectively.RESULTS Twenty-nine patients had (34.9%) T1a, 29 patients had (34.9%) T1b and 25 patients had (30.1%) T2 stage disease. During a median follow-up of 56 months, 13 patients had failures. Five year local control rates were 90.5% in T1 and 73.2% in T2 patients. Locoregional control rates were 89% in T1 and 70.5% in T2 patients. Treatment interruption more than 5 days was noted as a prognostic factor affecting local and locoregional control. Five year disease specific survival rates were 94% in T1 and 79% in T2 patients, T stage and radiotherapy interruption more than 5 days were noted as prognostic factors affecting disease specific survival.CONCLUSION Curative radiotherapy is an effective treatment modality in early stage glottic laryngeal cancer.

Özet

AMAÇ Küratif radyoterapi uygulanan erken evre glottik larenks kanserli olgularda tedavi sonuçları ve prognostik faktörlerin değerlendirilmesidir.GEREÇ VE YÖNTEM 1995-2004 yılları arasında Ege Üniversitesi Tıp Fakültesi Radyasyon Onkolojisi Anabilim Dalında, küratif radyoterapi uygulanan 83 hasta (80 erkek; 3 kadın; ort. yaş 62; dağılım 40-85) geriye dönük olarak değerlendirildi.BULGULAR Değerlendirmeye alınan 83 olgunun 29'u (%34.9) T1a, 29'u (%34.9) T1b, 25'i (%30.1) T2 evresinde idi. Ortalama 56 aylık takipte toplam 13 olguda yineleme görüldü. Beş yıllık lokal kontrol oranları T1 olgularda %90.5, T2 olgularda %73.2, lokal bölgesel kontrol oranları ise T1 olgularda %89, T2 olgularda %70.5 idi. Radyoterapiye beş günden fazla ara verilmesi lokal, lokal-bölgesel kontrolü etkileyen prognostik faktör olarak saptandı. Beş yıllık hastalığa özgü sağkalım oranları; T1 olgularda %94, T2 olgularda %79 olarak belirlendi; T evresi ve radyoterapiye beş günden fazla ara verilmesi hastalığa özgü sağkalımı etkileyen prognostik faktörler olarak saptandı.SONUÇ Erken evre glottik larenks kanserlerinde, tek başına küratif radyoterapi, etkin bir tedavi modelidir.

🔖

Cite This Article

KAMER, S., AYDIN, B., ESASSOLAK, M., DUBOVA, S. (2022). Curative radiotherapy in early stage glottic laryngeal carcinoma. Türk Onkoloji Dergisi, Cilt: 21 - Sayı: 1, 28–36. https://ajindex.com/articles/639426

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 glottic carcinomas. Cancer 2004;100(9):1786-92
  2. Rosier JF, Gregoire V, Counoy H, Octave-Prignot M, Rombaut P, Scalliet P, et al. Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. Radiother Oncol 1998;48(2):175-83
  3. Stewart MG, Chen AY, Stach CB. Outcomes analysis of voice and quality of life in patients with laryngeal cancer. Arch Otolaryngol Head Neck Surg 1998;124(2):143-8
  4. Verdonck-de Leeuw IM, Hilgers FJ, Keus RB, Koopmans-van Beinum FJ, Greven AJ, de Jong JM, et al. Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope 1999;109(2 Pt 1):241 8
  5. Sewnaik A, Meeuwis CA, van der Kwast TH, Kerrebijn JD. Partial laryngectomy for recurrent glottic carcinoma after radiotherapy. Head Neck 2005;27(2):101-7
  6. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001;19(20):4029-36
  7. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;39(1):115-26
  8. Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, et al. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998;41(2):347-53
  9. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twicedaily treatment? Int J Radiat Oncol Biol Phys 2003;55(2):322-8
  10. Demiral AN, Sarıoğlu S, Birlik B, Sen M, Kinay M. Prognostic significance of EGF receptor expression in early glottic cancer. Auris Nasus Larynx 2004;31(4):417-24
  11. Nix P, Cawkwell L, Patmore H, Greenman J, Stafford N. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer 2005;9212):2185-9. 12.AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002. Chap. 5
  12. Franchin G, Minatel E, Gobitti C, Talamini R, Sartor G, Caruso G, et al. Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis. Int J Radiat Oncol Biol Phys 1998;40(3):541-8
  13. Marshak G, Brenner B, Shvero J, Shap